BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32234406)

  • 1. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.
    Scherlinger M; Mertz P; Sagez F; Meyer A; Felten R; Chatelus E; Javier RM; Sordet C; Martin T; Korganow AS; Guffroy A; Poindron V; Richez C; Truchetet ME; Blanco P; Schaeverbeke T; Sibilia J; Devillers H; Arnaud L
    Autoimmun Rev; 2020 Jun; 19(6):102531. PubMed ID: 32234406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
    Bernardino V; Rodrigues A; Lladó A; Panarra A
    Rheumatol Int; 2020 Feb; 40(2):295-301. PubMed ID: 31451935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
    Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
    Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of systemic and thyroid autoimmune diseases.
    Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
    Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
    Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
    Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19.
    Kouranloo K; Dey M; Elwell H; Nune A
    Rheumatol Int; 2023 Jul; 43(7):1221-1243. PubMed ID: 36786873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and its risk factors in critically ill patients with connective tissue diseases: A meta-analysis.
    Kouchit Y; Morand L; Martis N
    Eur J Intern Med; 2022 Apr; 98():83-92. PubMed ID: 35151541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality and long term survival prognostic factors of patients with systemic autoimmune diseases admitted to an intensive care unit: a retrospective study.
    Antón JM; Castro P; Espinosa G; Marcos M; Gandía M; Merchán R; Cervera R; Nicolás JM
    Clin Exp Rheumatol; 2012; 30(3):338-44. PubMed ID: 22338619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review.
    Mucke J; Cornet A; Witte T; Schneider M
    Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):40-45. PubMed ID: 35349404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
    McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
    Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
    Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secular Trends in Systemic Sclerosis Mortality in the United States from 1981 to 2020.
    Li JX
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
    Whittingham S; Mackay IR; Tait BD
    Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.
    Yen EY; Singh DR; Singh RR
    Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1502-1510. PubMed ID: 32770721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study.
    Yen EY; Shaheen M; Woo JMP; Mercer N; Li N; McCurdy DK; Karlamangla A; Singh RR
    Ann Intern Med; 2017 Dec; 167(11):777-785. PubMed ID: 29086801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of circulating anti-N-methyl-
    Tay SH; Fairhurst AM; Mak A
    Autoimmun Rev; 2017 Feb; 16(2):114-122. PubMed ID: 27988431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
    Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
    Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.